Flexion Therapeutics Raises $33 Million
Flexion Therapeutics, a Woburn, Mass.-based drug development startup, has raised $33 million in Series A funding. Versant Ventures led the round, and was joined by 5AM Ventures and Sofinnova Ventures. Flexion was formed in 2007 by Chorus co-founders Mike Clayman and Neil Bodick.
18 October 2009•3 mins read
